Claudia Capparelli

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Top Venues

Molecular cancer research : MCR

Nature cell biology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Dan Filipescu, Saul Carcamo, Aman Agarwal, Navpreet Tung, Etienne Humblin, Matthew S Goldberg, Nikki S Vyas, Kristin G Beaumont, Deniz Demircioglu, Subhasree Sridhar, Flavia G Ghiraldini, Claudia Capparelli, Andrew E Aplin, Hélène Salmon, Robert P Sebra, Alice Oliffson Kamphorst, Miriam Merad, Dan Hasson, Emily Bernstein
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping. Nature cell biology (2023)
Sheera R Rosenbaum, Signe Caksa, Casey D Stefanski, Isabella V Trachtenberg, Haley P Wilson, Nicole A Wilski, Connor A Ott, Timothy J Purwin, Jelan I Haj, Danielle Pomante, Daniel Kotas, Inna Chervoneva, Claudia Capparelli, Andrew E Aplin
SOX10 loss sensitizes melanoma cells to cytokine-mediated inflammatory cell death. Molecular cancer research : MCR (2023)
McKenna Q Glasheen, Signe Caksa, Amelia G Young, Nicole A Wilski, Connor A Ott, Inna Chervoneva, Keith T Flaherty, Meenhard Herylyn, George X Xu, Andrew E Aplin, Claudia Capparelli
Targeting up-regulated cIAP2 in SOX10-deficient drug tolerant melanoma. Molecular cancer therapeutics (2023)